Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.

Moghadamchargari, Zahra; Shirzadeh, Mehdi; Liu, Chang; Schrecke, Samantha; Packianathan, Charles; Russell, David H; Zhao, Minglei; Laganowsky, Arthur · Proc Natl Acad Sci U S A · 2021

basic_science · Level V

Where this comes from

Abstract

Ras is regulated by a specific guanine nucleotide exchange factor Son of Sevenless (SOS), which facilitates the exchange of inactive, GDP-bound Ras with GTP. The catalytic activity of SOS is also allosterically modulated by an active Ras (Ras-GTP). However, it remains poorly understood how oncogenic Ras mutants interact with SOS and modulate its activity. Here, native ion mobility-mass spectrometry is employed to monitor the assembly of the catalytic domain of SOS (SOS<sup>cat</sup>) with KRas and three cancer-associated mutants (G12C, G13D, and Q61H), leading to the discovery of different molecular assemblies and distinct conformers of SOS<sup>cat</sup> engaging KRas. We also find KRas<sup>G13D</sup> exhibits high affinity for SOS<sup>cat</sup> and is a potent allosteric modulator of its activity. A structure of the KRas<sup>G13D</sup>•SOS<sup>cat</sup> complex was determined using cryogenic electron microscopy providing insight into the enhanced affinity of the mutant protein. In addition, we find that KRas<sup>G13D</sup>-GTP can allosterically increase the nucleotide exchange rate of KRas at the active site more than twofold compared to KRas-GTP. Furthermore, small-molecule Ras•SOS disruptors fail to dissociate KRas<sup>G13D</sup>•SOS<sup>cat</sup> complexes, underscoring the need for more potent disruptors. Taken together, a better understanding of the interaction between oncogenic Ras mutants and SOS will provide avenues for improved therapeutic interventions.

Medical subject headings